COVID Fight: Delhi health minister thanks Shah Rukh Khan for donating Remdesivir injections
Celebrities | Dec 10, 2020, 05:56 PM ISTDelhi Health Minister Satyendar Jain thanked Bollywood actor Shah Rukh Khan for donating 500 Remdesivir injections.
Delhi Health Minister Satyendar Jain thanked Bollywood actor Shah Rukh Khan for donating 500 Remdesivir injections.
World Health Organization guidelines panel advised against using the antiviral remdesivir for hospitalized patients, saying there’s no evidence it improves survival or avoids the need for breathing machines.
The Supreme Court Thursday sought response from the Centre on a plea alleging that two medicines Remdesivir and Favipiravir, are being used for treatment of COVID-19 without approval.
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.
Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found. The antiviral medication was among the first to be used as a treatment for COVID-19.
A batch of Remdesivir for treatment of COVID-19 patients has been withdrawn in view of 'sub-standard quality' of the medicine, Maharashtra Health Minister Rajesh Tope said on Wednesday.
Amid surge of coronavirus cases in Odisha, the state government has allowed the sale of Favipiravir tablet and Remdesivir injectable formulation in stores for the treatment of coronavirus patients on Saturday.
Dr. Reddys Laboratories Ltd on Wednesday announced the launch of Remdesivir, meant for treatment of COVID-19 patients, under a brand name 'Redyx' in India.
The company will make the drug available to over 1,000 hospitals providing COVID-19 treatment, Jubilant Life Sciences said in a statement.
The Union health ministry has asked the Drugs Controller General of India to ensure equitable distribution of Remdesivir and Tocilizumab drugs, which have been included as "investigational therapies" in the national treatment protocols for COVID-19, across the country.
Canada has announced its authorisation for using the drug remdesivir for treating patients suffering severe symptoms of Covid-19 who have pneumonia and require extra oxygen to help them breathe.
Noida-headquartered Jubilant Life Science has reportedly received permission to manufacture Remdesivir for emergency use with same conditions as given to other companies like Hetero, Cipla and Mylan.
Pharma major Mylan on Monday said it has commercially launched the generic version of Remdesivir drug under the brand name 'Desrem' in India for treatment of coronavirus patients.
Covifor is the first generic brand of Remdesivir, which is meant for treatment of COVID-19 patients that are adults and children, hospitalised with severe symptoms of the disease.
The Indian Council of Medical Research (ICMR) and the All India Institute of Medical Sciences (AIIMS) have asked states to use drugs like remdesivir and tocilizumab, mentioned as investigational therapies, on COVID-19 patients strictly as per the laid down protocol as their "indiscriminate use or use in conditions for which they are not desirable may cause more harm than good".
New data revealed by Gilead Sciences has shown that its antiviral drug remdesivir reduces death risk of severe Covid-19 patients by as much as 62 per cent when compared with standard care alone.
Doctors in state hospitals are being advised to use antiviral Remdesivir on COVID-19 patients strictly as per protocol amid some reports of liver damage in such patients treated with the drug, official sources said.
Several cities across India, including Mumbai, Bangalore are reportedly facing a shortage of the experimental antiviral drug Remdesivir. Delhi is also struggling to source it from other cities or buying it at exorbitant prices. In Delhi, both private and government hospitals have reported depleting stock of the coronavirus medicine.
Amid news that the US has bought up virtually the entire global supply of remdesivir, a new study outlines how the drug could save lives in countries with a lower hospital capacity, such as South Africa, where Covid-19 is beginning to overwhelm intensive care units (ICUs).
Pharma major Cipla on Wednesday said it has launched its generic version of antiviral drug remdesivir at a price which is among the lowest globally and is looking to supply over 80,000 vials within the first month.
Top News
Latest News